CASI Pharmaceuticals Inc. (CASI)
NASDAQ: CASI
· Real-Time Price · USD
2.35
0.41 (21.13%)
At close: Aug 15, 2025, 3:59 PM
2.00
-14.89%
After-hours: Aug 15, 2025, 07:47 PM EDT
CASI Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.75M | -14.37M | -8.39M | -6.96M | -9.53M | -6.05M | -4.63M | -10.24M | -6.01M | -19.34M | -5.02M | -7.49M | -8.4M | -5.39M | -10.02M | -6.74M | -13.68M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 890K | 765K | 334K | 433K | 413K | 421K | 465K | 516K |
Stock-Based Compensation | n/a | 1.31M | n/a | n/a | n/a | 7.22M | n/a | n/a | n/a | 1.42M | 1.76M | 1.92M | 1.91M | 2.71M | 2.02M | 1.04M | 2M |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.34M | 14K | -1.35M | -323K | 3.35M | -1.08M | -912K | -353K |
Other Non-Cash Items | 10.75M | 13.06M | 8.39M | 6.96M | 9.53M | -1.16M | 4.63M | 10.24M | 6.01M | 13.48M | -449K | 1.49M | 1.86M | 249K | 344K | 1.39M | 5.85M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.87M | 3.21M | -984K | -1.57M |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.7M | -3.58M | -5.74M | -42K | 246K | 158K | -2.51M | -1.11M |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -843K | -6.52M | -9.48M | -4.24M | -7.64M | -3.86M | -7.34M | -8M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.43M | -467K | 569K | -2.29M | -5.21M | -2.83M | -977K | -6.48M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.29M | n/a | 1.29M | n/a | n/a | 10K | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.46M | n/a | -2.96M | n/a | 5.59M | -566K | -750K | -5.59M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.41M | 16.92M | 1.29M | n/a | n/a | 172K | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.73M | 16.92M | -1.16M | n/a | -5.11M | -79K | -750K | -5.59M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.95M | 16.45M | -961K | -2.29M | -4.74M | -2.91M | -977K | -12.07M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3M | 2M | 1M | n/a | -1.08M | -463K | n/a | 709K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -267K | n/a | n/a | -3M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.02M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.27M | 2M | 1M | -3M | -1.08M | -463K | n/a | 31.19M |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.87M | 10.38M | -10.4M | -9.45M | -14.42M | -7.23M | -7.76M | 11.05M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.27M | -6.99M | -8.91M | -6.53M | -12.86M | -6.69M | -8.32M | -14.48M |